Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 12, 2013, Pages 1335-1340

  Thabut, Gabriel ^a,b   Christie, Jason D ^c   Mal, Hervé ^a,b   Fournier, Michel ^a   Brugière, Olivier ^a,b   Leseche, Guy ^a   Castier, Yves ^a,b   Rizopoulos, Dimitris ^d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cystic fibrosis; Epidemiology; Lung transplantation

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LUNG ALLOCATION SCORE; LUNG CYSTIC FIBROSIS; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; SURVIVAL TIME;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS; YOUNG ADULT;

EID: 84879566891     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201303-0429OC     Document Type: Article

References (25)

1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009;373: 1891-1904.
2. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The registry of the International Society for Heart and Lung Transplantation: twentyeighth adult lung and heart-lung transplant report-2011. J Heart Lung Transplant 2011;30: 1104-1122.
3. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011;184: 159-171.
4. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al.; VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365: 1663-1672.
5. Liou TG, Adler FR, Cahill BC, Cox DR. Correction: lung transplantation and survival in children with cystic fibrosis. N Engl JMed 2008;359: 536.
6. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286: 2683-2689.
7. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Priorities for lung transplantation among patients with cystic fibrosis. JAMA 2002;287: 1523-1524, author reply 1524-1525.
8. Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357: 2143-2152.
9. Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005;171: 1053-1059.
10. Liou TG, Woo MS, Cahill BC. Lung transplantation for cystic fibrosis. Curr Opin Pulm Med 2006;12: 459-463.
11. Crowley J, Hu M. Covariance analysis of heart transplant survival data. JASA 1977;72: 27-36.
12. Rizopoulos D. Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data. Biometrics 2011;67: 819-829.
13. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6: 1212-1227.
14. Ibrahim JG, Chu H, Chen LM. Basic concepts and methods for joint models of longitudinal and survival data. J Clin Oncol 2010;28: 2796-2801.
15. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data, 2nd ed. New York: John Wiley; 2002.
16. Tsiatis A, Davidian M. Joint modeling of longitudinal and time to event data: an overview. Stat Sin 2004;14: 809-834.
17. Prentice RL. Covariate measurement errors and parameter estimates in a failure time regression model. Biometrika 1982;69: 331-342.
18. Sweeting MJ, Thompson SG. Joint modelling of longitudinal and timeto- event data with application to predicting abdominal aortic aneurysm growth and rupture. Biom J 2011;53: 750-763.
19. Rizopoulos D. JM: an R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw 2010;35: 1-33.
20. Thabut G, Fournier M. Assessing survival benefits from lung transplantation. Rev Mal Respir 2011;28: e1-e6.
21. Vanlemmens C,Di Martino V,Milan C, MessnerM,Minello A, Duvoux C, Poynard T, Perarnau JM, PiquetMA, Pageaux GP, et al.; TRANSCIAL Study Group. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial. Ann Intern Med 2009;150: 153-161.
22. Thabut G, Mal H, Castier Y, Groussard O, Brugière O, Marrash-Chahla R, Lesèche G, Fournier M. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003;126: 469-475.
23. Aurora P, Spencer H, Moreno-Galdó A. Lung transplantation in children with cystic fibrosis: a view from Europe. Am J Respir Crit Care Med 2008;177: 935-936.
24. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351: 24-27.
25. Kotloff RM. Does lung transplantation confer a survival benefit? Curr Opin Organ Transplant 2009;14: 499-503.